Substituted imidazoles having anti-cancer and cytokine inhibitory
申请人:Merck & Co., Inc.
公开号:US05717100A1
公开(公告)日:1998-02-10
Compounds represented by formula I: ##STR1## are disclosed. AR represents an aromatic group containing 6-10 atoms; and ##STR2## represents a 4 to 6 membered non-aromatic heterocycle containing only one N atom. A pharmaceutical composition is also included. Methods of treating cancer and cytokine mediated diseases are also included.
[EN] MODULATORS OF HCV REPLICATION<br/>[FR] MODULATEURS DE LA REPLICATION DU VHC
申请人:ANGELETTI P IST RICHERCHE BIO
公开号:WO2006021449A1
公开(公告)日:2006-03-02
The present invention is directed to the use of certain 2,4,5-trisubstituted imidazole derivatives in modulating the replication of Hepatitis C virus RNA and/or virus production in cells.
[EN] CERTAIN 1,4,5-TRI-SUBSTITUTED IMIDAZOLE COMPOUNDS USEFUL AS CYTOKINE<br/>[FR] CERTAINS COMPOSES D'IMIDAZOLE 1,4,5-TRISUBSTITUES UTILES COMME CYTOKINE
申请人:SMITHKLINE BEECHAM CORPORATION
公开号:WO1996021452A1
公开(公告)日:1996-07-18
(EN) This invention relates to certain 5-(optionally substituted aryl or heteroaryl)-4-(optionally substituted heteroaryl)-1-(optionally substituted heterocyclyl or heterocyclylalkyl) or 1- optionally substituted alkyl or alkenyl -imidazoles and derivatives thereof. Synthetic processes for the preparation of said tri-substituted imidazoles is described. The aforementioned imidazoles are useful for treating cytokine mediated diseases. The compounds of the invention are incorporated into pharmaceutical compositions for use in treating cytokine related diseases.(FR) L'invention concerne certains imidazoles 5-(aryle ou hétéroaryle éventuellement substitué)-4-(hétéroaryle éventuellement substitué)-1-(hétérocyclyle ou hétérocyclylalkyle éventuellement substitué) ou 1-alcényle ou alkyle éventuellement substitué et des dérivés de ces imidazoles. L'invention concerne également des procédés de synthèse pour la préparation de ces imidazoles trisubstitués. Ces imidazoles sont utiles pour traiter les maladies induites par la cytokine. Les composés de l'invention sont incorporés dans des compositions pharmaceutiques permettant de traiter les maladies liées à la cytokine.